Integrative Psychiatry Effective but Overlooked for Cancer Patients
Nearly three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment programme is strikingly more effective at reducing depression and improving quality of life than current care, according to three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology. Lead author Professor Michael Sharpe from the University of Oxford in the UK, says “The huge benefit that DCPC delivers for patients with cancer and depression shows what we can achieve for patients if we take as much care with the treatment of their depression as we do with the treatment of their cancer.” By M Sharpe, et al., published in the Lancet and Lancet Oncology, Aug. 2014.
